EP1893213
Samsetning pýrimídýlamínóbensamíð efnasamband og ímatíníbís til að meðhöndla eða fyrirbyggja viðkomusjúkdóma.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.6.2006EP published:
17.2.2010EP application number:
06760628.5
EP translation filed:
27.4.2010Grant published:
15.5.2010EPO information:
European Patent Register
Max expiry date:
1.6.2026Expiry date:
2.6.2014
Title:
COMBINATION OF PYRIMIDYLAMINOBENZAMIDE COMPOUNDS AND IMATINIB FOR TREATING OR PREVENTING PROLIFERATIVE DISEASES
Timeline
Today
2.6.2006EP application
17.2.2010EP Publication
27.4.2010Translation submitted
15.5.2010Registration published
2.6.2014Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
ALLAND, LeilaAddress:
Chatham, New Jersey, US
Name:
MANLEY, Paul, W.Address:
Arlesheim, CH
Name:
MESTAN, JuergenAddress:
Denzlingen, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
687758 PDate:
3.6.2005Country:
US
Classification
Categories:
A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 5.5.2010
Expires: 2.6.2011
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 4.5.2011
Expires: 2.6.2012
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 7.5.2012
Expires: 2.6.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.5.2013
Expires: 2.6.2014
Payer: Árnason Faktor